3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Breast Neoplasms
3
Papillomavirus Infections
2
Melanoma
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Sarcoma
1
Prostatic Neoplasms
1
Neuroblastoma
1
Neoplasms, Nerve Tissue
1
NY-ESO-1-expressing Tumors
1
Leukemia, Myeloid, Acute
1
Herpes Zoster
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Condylomata Acuminata
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Anus Neoplasms
1
Adenoviridae Infections
1
Adenocarcinoma
1
Interventions
Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Herpes Zoster
×
Vaccines
×
Clear all
NCT01460719
2019-03-11
V212-013
Merck Sharp & Dohme LLC
Phase 1
Completed
80 enrolled
13 charts